{"title":"急性缺血脑卒中患者血清铁和游离血红蛋白浓度的变化","authors":"Faezeh Ghadiani, D. Qujeq, A. A. Ahangar","doi":"10.22037/JPS.V7I3.11423","DOIUrl":null,"url":null,"abstract":"A number of evidences suggest that during ischemic stroke, serum iron and hemoglobin (Hb) levels are changed. Yet, there are few reports in the literature related to this issue and resolution of this mechanism requires further experiments. The aim of the present study was to investigate the potential role of serum iron and hemoglobin levels as a biomarker in diagnosis of acute ischemic stroke. The sample size was 60 ischemic stroke patients who were admitted to the Rouhhani hospital in Babol, with 60 healthy volunteers selected as control group. Clinical evaluation consisted of complete medical history and physical examination and neuro-imaging's studies. Sampling strategy was based on clinical characteristics, including age, gender, and history of diseases. Laboratory measurements were performed in the department of clinical biochemistry. Serum iron and plasma hemoglobin levels were measured by standard kit of iron and hemoglobin ELISA Kit, as of the manufactures' manual. Data were analyzed through statistical software SPSS version 22. The mean level of serum iron and hemoglobin in patients with acute ischemic stroke were higher than those in control group (P 0.05). Our results reinforce the possibility of serum iron and hemoglobin as biomarker in diagnosis of ischemic stroke patients.","PeriodicalId":16663,"journal":{"name":"Journal of paramedical sciences","volume":"77 1","pages":"24-28"},"PeriodicalIF":0.0000,"publicationDate":"2016-07-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Serum Iron and Free Hemoglobin Concentrations in Patients with Acute Ischemia Stroke\",\"authors\":\"Faezeh Ghadiani, D. Qujeq, A. A. Ahangar\",\"doi\":\"10.22037/JPS.V7I3.11423\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"A number of evidences suggest that during ischemic stroke, serum iron and hemoglobin (Hb) levels are changed. Yet, there are few reports in the literature related to this issue and resolution of this mechanism requires further experiments. The aim of the present study was to investigate the potential role of serum iron and hemoglobin levels as a biomarker in diagnosis of acute ischemic stroke. The sample size was 60 ischemic stroke patients who were admitted to the Rouhhani hospital in Babol, with 60 healthy volunteers selected as control group. Clinical evaluation consisted of complete medical history and physical examination and neuro-imaging's studies. Sampling strategy was based on clinical characteristics, including age, gender, and history of diseases. Laboratory measurements were performed in the department of clinical biochemistry. Serum iron and plasma hemoglobin levels were measured by standard kit of iron and hemoglobin ELISA Kit, as of the manufactures' manual. Data were analyzed through statistical software SPSS version 22. The mean level of serum iron and hemoglobin in patients with acute ischemic stroke were higher than those in control group (P 0.05). Our results reinforce the possibility of serum iron and hemoglobin as biomarker in diagnosis of ischemic stroke patients.\",\"PeriodicalId\":16663,\"journal\":{\"name\":\"Journal of paramedical sciences\",\"volume\":\"77 1\",\"pages\":\"24-28\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2016-07-02\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of paramedical sciences\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.22037/JPS.V7I3.11423\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of paramedical sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.22037/JPS.V7I3.11423","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
许多证据表明,在缺血性中风期间,血清铁和血红蛋白(Hb)水平发生改变。然而,文献中有关这一问题的报道很少,解决这一机制需要进一步的实验。本研究的目的是探讨血清铁和血红蛋白水平作为诊断急性缺血性中风的生物标志物的潜在作用。样本量为60例在巴博勒鲁哈尼医院住院的缺血性脑卒中患者,选择60名健康志愿者作为对照组。临床评价包括完整的病史、体格检查和神经影像学检查。抽样策略基于临床特征,包括年龄、性别和疾病史。实验室测量在临床生物化学系进行。血清铁和血浆血红蛋白水平采用铁和血红蛋白酶联免疫吸附测定试剂盒(ELISA kit)标准试剂盒,参照制造商手册。数据分析采用SPSS version 22统计软件。急性缺血性脑卒中患者血清铁、血红蛋白平均水平高于对照组(P < 0.05)。我们的结果加强了血清铁和血红蛋白作为诊断缺血性脑卒中患者的生物标志物的可能性。
Serum Iron and Free Hemoglobin Concentrations in Patients with Acute Ischemia Stroke
A number of evidences suggest that during ischemic stroke, serum iron and hemoglobin (Hb) levels are changed. Yet, there are few reports in the literature related to this issue and resolution of this mechanism requires further experiments. The aim of the present study was to investigate the potential role of serum iron and hemoglobin levels as a biomarker in diagnosis of acute ischemic stroke. The sample size was 60 ischemic stroke patients who were admitted to the Rouhhani hospital in Babol, with 60 healthy volunteers selected as control group. Clinical evaluation consisted of complete medical history and physical examination and neuro-imaging's studies. Sampling strategy was based on clinical characteristics, including age, gender, and history of diseases. Laboratory measurements were performed in the department of clinical biochemistry. Serum iron and plasma hemoglobin levels were measured by standard kit of iron and hemoglobin ELISA Kit, as of the manufactures' manual. Data were analyzed through statistical software SPSS version 22. The mean level of serum iron and hemoglobin in patients with acute ischemic stroke were higher than those in control group (P 0.05). Our results reinforce the possibility of serum iron and hemoglobin as biomarker in diagnosis of ischemic stroke patients.